Literature DB >> 3872844

Effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b.

G B Toews, D A Hart, E J Hansen.   

Abstract

The effect of systemic immunization on pulmonary clearance of Haemophilus influenzae type b (Hib) was studied in a mouse model system. Immunization of mice by intraperitoneal injection of viable Hib cells resulted in the appearance of Hib-directed antibodies in both serum and bronchoalveolar lavage fluid. The development of this Hib-directed antibody activity was associated with significant enhancement of early pulmonary clearance of Hib. Systemic immunization did not affect the recruitment of polymorphonuclear leukocytes to the alveoli, suggesting that the enhanced clearance of Hib observed in immunized animals was due to specific antibodies which promote either phagocytosis or extracellular killing of Hib. The spectrum of Hib-directed antibody specificities detected in sera from immunized animals was essentially identical to that detected in bronchoalveolar lavage fluids from these same animals. Similarly, intravenous administration of an immunoglobulin G monoclonal antibody specific for Hib lipopolysaccharide resulted in the subsequent appearance of this antibody in the alveolar spaces where it enhanced pulmonary clearance of Hib. This study shows that this mouse model system can be used to measure the effect of both active and passive immunization on the clearance of Hib from the lower respiratory tract.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3872844      PMCID: PMC261311          DOI: 10.1128/iai.48.2.343-349.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Pulmonary host defenses. II. Interaction of respiratory antibodies with Pseudomonas aeruginosa and alveolar macrophages.

Authors:  H Y Reynolds; R E Thompson
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

2.  Pulmonary host defenses. I. Analysis of protein and lipids in bronchial secretions and antibody responses after vaccination with pseudomonas aeruginosa.

Authors:  H Y Reynolds; R E Thompson
Journal:  J Immunol       Date:  1973-08       Impact factor: 5.422

3.  Acute respiratory infections in children. A global public-health problem.

Authors:  J Chretien; W Holland; P Macklem; J Murray; A Woolcock
Journal:  N Engl J Med       Date:  1984-04-12       Impact factor: 91.245

4.  The role of C5 in polymorphonuclear leukocyte recruitment in response to Streptococcus pneumoniae.

Authors:  G B Toews; W C Vial
Journal:  Am Rev Respir Dis       Date:  1984-01

5.  Experimental pneumonia due to Haemophilus influenzae: observations on pathogenesis and treatment.

Authors:  A L Esposito; J E Pennington
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

6.  Pulmonary clearance of encapsulated and unencapsulated Haemophilus influenzae strains.

Authors:  G B Toews; S Viroslav; D A Hart; E J Hansen
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

7.  Immunoglobulin A from bronchopulmonary secretions blocks bactericidal and opsonizing effects of antibody to nontypable Haemophilus influenzae.

Authors:  D M Musher; A Goree; R E Baughn; H H Birdsall
Journal:  Infect Immun       Date:  1984-07       Impact factor: 3.441

8.  Characterization of the extracellular bactericidal factors of rat alveolar lining material.

Authors:  J D Coonrod; R L Lester; L C Hsu
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

9.  A set of two monoclonal antibodies specific for the cell surface-exposed 39K major outer membrane protein of Haemophilus influenzae type b defines all strains of this pathogen.

Authors:  P A Gulig; C F Frisch; E J Hansen
Journal:  Infect Immun       Date:  1983-11       Impact factor: 3.441

10.  THE ROLE OF THE ALVEOLAR MACROPHAGE IN THE CLEARANCE OF BACTERIA FROM THE LUNG.

Authors:  G M GREEN; E H KASS
Journal:  J Exp Med       Date:  1964-01-01       Impact factor: 14.307

View more
  11 in total

1.  Mechanism of pertussis toxin B oligomer-mediated protection against Bordetella pertussis respiratory infection.

Authors:  R D Shahin; M H Witvliet; C R Manclark
Journal:  Infect Immun       Date:  1990-12       Impact factor: 3.441

2.  Mucosal immunization with filamentous hemagglutinin protects against Bordetella pertussis respiratory infection.

Authors:  R D Shahin; D F Amsbaugh; M F Leef
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

3.  Analysis of protective and nonprotective monoclonal antibodies specific for Bordetella pertussis lipooligosaccharide.

Authors:  R D Shahin; J Hamel; M F Leef; B R Brodeur
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

4.  Lipooligosaccharides containing phosphorylcholine delay pulmonary clearance of nontypeable Haemophilus influenzae.

Authors:  Bing Pang; Dana Winn; Ryan Johnson; Wenzhou Hong; Shayla West-Barnette; Nancy Kock; W Edward Swords
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

5.  Bordetella pertussis filamentous hemagglutinin: evaluation as a protective antigen and colonization factor in a mouse respiratory infection model.

Authors:  A Kimura; K T Mountzouros; D A Relman; S Falkow; J L Cowell
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

6.  Diminished ICAM-1 expression and impaired pulmonary clearance of nontypeable Haemophilus influenzae in a mouse model of chronic obstructive pulmonary disease/emphysema.

Authors:  Bing Pang; Wenzhou Hong; Shayla L West-Barnette; Nancy D Kock; W Edward Swords
Journal:  Infect Immun       Date:  2008-09-15       Impact factor: 3.441

7.  Tracking insertion mutants within libraries by deep sequencing and a genome-wide screen for Haemophilus genes required in the lung.

Authors:  Jeffrey D Gawronski; Sandy M S Wong; Georgia Giannoukos; Doyle V Ward; Brian J Akerley
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-04       Impact factor: 11.205

8.  Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats.

Authors:  A W Cripps; M L Dunkley; R L Clancy
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

9.  DAMP molecule S100A9 acts as a molecular pattern to enhance inflammation during influenza A virus infection: role of DDX21-TRIF-TLR4-MyD88 pathway.

Authors:  Su-Yu Tsai; Jesus A Segovia; Te-Hung Chang; Ian R Morris; Michael T Berton; Philippe A Tessier; Mélanie R Tardif; Annabelle Cesaro; Santanu Bose
Journal:  PLoS Pathog       Date:  2014-01-02       Impact factor: 6.823

10.  Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis.

Authors:  R D Shahin; M J Brennan; Z M Li; B D Meade; C R Manclark
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.